お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
577224

世界の結核 (TB) 診断市場:2017~2021年

Global Tuberculosis (TB) Diagnostics Market 2017-2021

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 91 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.87円
世界の結核 (TB) 診断市場:2017~2021年
出版日: 2017年11月02日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 91 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

20世紀、結核は主な死因でした。しかし今日多くの症例は抗生剤で治癒します。世界の結核 (TB) 診断市場は2017~2021年にかけCAG3.56%で拡大すると予測されています。

当レポートでは、世界の結核 (TB) 診断市場について調査し、市場の現状と将来的見通し、製品別、エンドユーザー別、地域別動向、および市場に参入する主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 調査方法

第4章 イントロダクション

第5章 市況

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第6章 製品別市場セグメンテーション

  • 概要
  • 文化
  • ツベルクリン反応
  • 分子試験
  • スメア顕微鏡検査
  • PLHIVのためのLF-LAM
  • 薬剤感受性試験

第7章 エンドユーザー別市場セグメンテーション

  • 概要
  • 病院
  • 診断試験所

第8章 地域別セグメンテーション

  • 概要
  • 地域別比較
  • アジア太平洋地域
  • 南北アメリカ
  • 欧州・中東・アフリカ
  • 主要国
  • 市場の機会

第9章 意思決定の枠組み

第10章 促進因子と課題

第11章 市場動向

第12章 ベンダー環境

  • 競合環境

第13章 ベンダー分析

  • Abbott
  • BD
  • bioMerieux
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
  • その他の注目すべきベンダー

第14章 付録

図表

目次
Product Code: IRTNTR15492

About Tuberculosis (TB) Diagnostics

TB is a contagious infection that usually attacks the lungs. It may also spread to other parts of the body such as the brain and the spine. TB commonly spreads through the air when an infected person coughs, sneezes, spits, laughs, or talks. Mycobacterium tuberculosis is responsible for the onset of the disease. In the 20th century, TB was a leading cause of death. However, today, most cases are cured with antibiotics, which is a time-consuming process. Medicines should be taken for at least six to nine months.

Technavio's analysts forecast the global tuberculosis (TB) diagnostics market to grow at a CAGR of 3.56% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global tuberculosis (TB) diagnostics market for 2017-2021. To calculate the market size, the report considers the new installations, shipments, sales, volume, and value.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Tuberculosis (TB) Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott
  • BD
  • bioMerieux
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Akonni Biosystems
  • Ameritek USA
  • Autobio Diagnostics
  • Cepheid
  • EIKEN CHEMICAL
  • GeTein BioMedical
  • Hain Lifescience
  • Hologic
  • NanoEnTek
  • Ortho Clinical Diagnostics
  • QIAGEN
  • Siemens Healthineers

Market driver

  • Increasing prevalence of TB
  • For a full, detailed list, view our report

Market challenge

  • Accessibility and cost constraints of advanced TB diagnostics
  • For a full, detailed list, view our report

Market trend

  • Expansion of healthcare infrastructure
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION

  • Overview

PART 05: MARKET LANDSCAPE

  • Overview
  • Market size and forecast
  • Five forces analysis

PART 06: SEGMENTATION BY PRODUCT TYPE

  • Overview
  • Culture
  • Mantoux tuberculin test
  • Molecular testing
  • Smear microscopy
  • LF-LAM for PLHIV
  • Drug susceptibility testing

PART 07: SEGMENTATION BY END-USER

  • Overview
  • Hospitals
  • Diagnostic laboratories

PART 08: SEGMENTATION BY GEOGRAPHY

  • Overview
  • Regional comparison
  • APAC
  • Americas
  • EMEA
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Focus on partnerships and acquisitions for product development
  • Continuous technological advances
  • Expansion of healthcare infrastructure

PART 12: VENDOR LANDSCAPE

  • Competitive landscape

PART 13: KEY VENDOR ANALYSIS

  • Abbott
  • BD
  • bioMerieux
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Other prominent vendors

PART 14: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Share of global TB diagnostics market of global IVD market 2016 (%)
  • Exhibit 02: Global TB diagnostics market 2016-2021 ($ billions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Global TB diagnostics market: Segmentation by product type 2016 (% share)
  • Exhibit 05: Global TB diagnostics market: Segmentation by end-user 2016 (% share)
  • Exhibit 06: Global TB diagnostics market by hospitals 2016-2021 ($ billions)
  • Exhibit 07: Global TB diagnostics market by hospitals: Year-over-year growth 2017-2021 (%)
  • Exhibit 08: Global TB diagnostic market by diagnostic laboratories 2016-2021 ($ billions)
  • Exhibit 09: Global TB diagnostics market by diagnostic laboratories: Year-over-year growth 2017-2021 (%)
  • Exhibit 10: Global TB diagnostics market: Segmentation by geography 2016-2021 (% share)
  • Exhibit 11: Global TB diagnostics market: Regional comparison
  • Exhibit 12: TB diagnostics market in APAC: Overview
  • Exhibit 13: TB diagnostics market in APAC 2016-2021 ($ billions)
  • Exhibit 14: TB diagnostics market in APAC: Year-over-year growth 2017-2021 (%)
  • Exhibit 15: TB diagnostics market in Americas: Overview
  • Exhibit 16: TB diagnostics market in Americas 2016-2021 ($ billions)
  • Exhibit 17: TB diagnostics market in Americas: Year-over-year growth 2017-2021 (%)
  • Exhibit 18: TB diagnostics market in EMEA: Overview
  • Exhibit 19: TB diagnostics market in EMEA 2016-2021 ($ billions)
  • Exhibit 20: TB diagnostics market in EMEA: Year-over-year growth 2017-2021 (%)
  • Exhibit 21: Global TB diagnostics market: Key leading countries
  • Exhibit 22: Global TB diagnostics market: Competitive structure analysis 2016
  • Exhibit 23: Abbott: Key highlights
  • Exhibit 24: Abbott: Strength assessment
  • Exhibit 25: Abbott: Strategy assessment
  • Exhibit 26: Abbott: Opportunity assessment
  • Exhibit 27: BD: Key highlights
  • Exhibit 28: BD: Strength assessment
  • Exhibit 29: BD: Strategy assessment
  • Exhibit 30: BD: Opportunity assessment
  • Exhibit 31: bioMerieux: Key highlights
  • Exhibit 32: bioMerieux: Strength assessment
  • Exhibit 33: bioMerieux: Strategy assessment
  • Exhibit 34: bioMerieux: Opportunity assessment
  • Exhibit 35: F. Hoffmann-La Roche: Key highlights
  • Exhibit 36: F. Hoffmann-La Roche: Strength assessment
  • Exhibit 37: F. Hoffmann-La Roche: Strategy assessment
  • Exhibit 38: F. Hoffmann-La Roche: Opportunity assessment
  • Exhibit 39: Thermo Fisher Scientific: Key highlights
  • Exhibit 40: Thermo Fisher Scientific: Strength assessment
  • Exhibit 41: Thermo Fisher Scientific: Strategy assessment
  • Exhibit 42: Thermo Fisher Scientific: Opportunity assessment
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.